Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial
Main Authors: | Ziegler, Dan, Low, Phillip A., Litchy, William J., Boulton, Andrew J.M., Vinik, Aaron I., Freeman, Roy, Samigullin, Rustem, Tritschler, Hans, Munzel, Ullrich, Maus, Joachim, Schütte, Klemens, Dyck, Peter J. |
---|---|
Format: | Online |
Language: | English |
Published: |
American Diabetes Association
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161301/ |
Similar Items
-
e-Learning / Devakhi Pandari Nathan
by: Devakhi Pandari, Nathan
Published: (2000) -
Impaired Glycemia and Diabetic Polyneuropathy: The OC IG Survey
by: Dyck, Peter J., et al.
Published: (2012) -
Mechanisms and Management of Diabetic Painful Distal Symmetrical Polyneuropathy
by: Tesfaye, Solomon, et al.
Published: (2013) -
Pathways in the Diagnosis and Management of Diabetic Polyneuropathy
by: Kaku, Michelle, et al.
Published: (2015) -
Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy
by: David Adams, et al.
Published: (2017-09-01)